Description
Description
Itaglip Plus (50mg/850mg) is a prescription anti-diabetic medicine manufactured by Sami Pharmaceuticals, combining Sitagliptin Phosphate and Metformin Hydrochloride in a single film-coated tablet for adults with type 2 diabetes mellitus. This combination brings together two well-established, complementary mechanisms of blood sugar control. Sitagliptin belongs to a class of medicines known as DPP-4 inhibitors, and works by blocking the breakdown of the body’s natural incretin hormones, which are released after eating and help stimulate insulin production in response to rising blood glucose. By preserving these hormones for longer, Sitagliptin enhances insulin secretion and helps reduce blood sugar levels. Metformin, one of the most established first-line diabetes medicines, works differently by inhibiting the liver’s production of glucose, interfering with the energy-generating processes within liver cells that would otherwise release excess sugar into the bloodstream. Together, these two mechanisms offer more comprehensive blood sugar control than either medicine alone, making Itaglip Plus a widely used option for patients whose diabetes isn’t adequately managed with metformin monotherapy. Each pack of Itaglip Plus (50mg/850mg) contains 14 tablets.
Ingredients
Each Itaglip Plus (50mg/850mg) tablet contains Sitagliptin Phosphate Monohydrate equivalent to 50mg of Sitagliptin, combined with 850mg of Metformin Hydrochloride. The tablet also contains standard pharmaceutical excipients that support its film coating, shape, and stability. Patients with a known allergy to either active ingredient, or to any inactive component, should avoid this medicine and should review the enclosed leaflet or consult a pharmacist regarding other known sensitivities.
Dosage Form
Itaglip Plus (50mg/850mg) is supplied as an oral, film-coated tablet intended to be swallowed whole with a glass of water. Tablets are packaged within protective blister strips inside an outer carton, with this pack containing a total of 14 tablets.
Uses
Itaglip Plus (50mg/850mg) is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus who are inadequately controlled on their maximum tolerated dose of Metformin alone, or who are already being treated with the combination of Sitagliptin and Metformin separately. It may also be used as part of triple combination therapy alongside a sulfonylurea, or added to insulin therapy in patients whose blood sugar remains inadequately controlled on insulin and Metformin alone. This medicine is not suitable for type 1 diabetes or diabetic ketoacidosis and should only be used under a physician’s supervision.
How To Use
Itaglip Plus is typically taken twice daily with meals, exactly as directed by the prescribing doctor, since dosing is individualized based on a patient’s current treatment regimen, effectiveness, and tolerability, while never exceeding the maximum recommended daily dose of 100mg of Sitagliptin. Taking the tablets with food helps reduce the gastrointestinal side effects commonly associated with the Metformin component. This medicine should be taken consistently as part of an ongoing diabetes management plan that includes regular blood sugar monitoring, and should never be stopped or adjusted without a doctor’s guidance.
Side Effects
Commonly reported side effects of Itaglip Plus include nausea, diarrhea, stomach discomfort, and reduced appetite, particularly during the initial period of treatment or following a dose increase. Some patients may also experience headache or upper respiratory symptoms. A rare but serious risk associated with the Metformin component is a condition called lactic acidosis, which can cause symptoms such as unusual muscle pain, difficulty breathing, stomach pain, or unusual tiredness, and requires immediate emergency medical attention. Less commonly, joint pain, skin reactions, or signs of pancreatitis, such as persistent and severe abdominal pain, have been reported with the Sitagliptin component and should be evaluated promptly by a doctor. Signs of a serious allergic reaction, including facial swelling or difficulty breathing, also require immediate medical care.
Pregnancy & Breastfeeding
Itaglip Plus is contraindicated during pregnancy, as blood sugar control during this period is typically managed with insulin rather than oral diabetes medicines, given the more established safety profile of insulin in this setting. Women who are pregnant, planning pregnancy, or who discover they are pregnant while taking this medicine should inform their doctor immediately so their treatment plan can be reassessed. Regarding breastfeeding, this medicine is generally not recommended, as it isn’t well established whether these active ingredients pass into breast milk in meaningful amounts, and a doctor should be consulted to explore suitable alternatives.
Storage Instructions
Itaglip Plus tablets should be stored at room temperature, protected from direct sunlight, excess heat, and moisture. Tablets should remain in their original blister packaging until needed, and the medicine should be stored securely out of reach and sight of children.
FAQs
Who should avoid taking Itaglip Plus?
It is contraindicated in pregnancy, and should be avoided in patients with significant renal or hepatic impairment, diabetic ketoacidosis, cardiac or respiratory failure, recent heart attack, or acute alcohol intoxication or alcoholism.
Can it be combined with other diabetes medicines?
Yes, it may be used alongside a sulfonylurea or insulin in certain patients, based on a doctor’s assessment of blood sugar control needs.
What is lactic acidosis, and why is it a concern?
It’s a rare but serious condition linked to the Metformin component, and any unusual muscle pain, breathing difficulty, or extreme tiredness should be treated as a medical emergency.
Is this medicine suitable for type 1 diabetes?
No, it is intended only for type 2 diabetes mellitus and should not be used for type 1 diabetes or diabetic ketoacidosis.
Disclaimer
Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.






Reviews
There are no reviews yet.